Is the world’s biggest maker of endoscopes with 70% of the global market now targeting the disposable device segment? Is the device market for Minimally invasive surgeries in greater demand as societies around the world age? Is the Gyrus PK System generator and instruments ability to cut and coagulate across a wide range of tissue […]
Category Archives: GERD
Olympus > First-Half Profit Falls 89% > Gyrus Costs > Endoscopes Married With Energy Device For Tissue Take Down And Fusion > Olympus Expands Medical Systems Business In Minimally Invasive Systems
Bard EndoCinch endosuturing system > Long-term outcome > Endoluminal gastroplication > Treatment of gastro-oesophageal reflux disease > Effect of a second procedure > Gastroenterology > University Hospital of North Norway
Does the development of innovative NOTES devices for improving the function of the lower esophageal sphincter LES continue? What role will Polymethylmethacrylate PMMA beads play in the thicken of the tissue and the strengthen of the LES when the microbeads are implanted in local tissue adjacent to the LES? Will the promising work in Endoscopic […]
Transoral Incisionless Fundoplication TIF > Effective for GERD > Safe and durable antireflux therapy > Fasteners used in TIF intact > No fracture stretching or dissolution > Decreased the number of extended reflux episodes > Randomized controlled trial > Blair A Jobe > University of Pittsburgh > Safe and reproduces the gold standard operation > Laparoscopic Nissen fundoplication
Is TIF an incisionless and outpatient procedure? Does TIF open the door to an anatomic reconstruction to the entire spectrum of patients with GERD? How is the primary endpoint of long-term symptom amelioration in the randomized controlled trial comparing transoral incisionless fundoplication with proton pump inhibitor therapy?
IIP > read on here > http://www.abkhazia.com…
Transoral incisionless fundoplication […]
New study > Long-term Results > Laparoscopic Nissen fundoplication > Anti-reflux Surgery > Massachusetts General Hospital > Harvard Medical School > Minimally invasive procedure > Gastroesophageal reflux disease GERD > Seventy-one percent of patients satisfied with long-term results > Primary or revision redo laparoscopic fundoplication > By single surgeon > Near normal scores of GERD−HRQL Health-Related Quality of Life Scale
Does the results of this study demonstrate that most patients undergoing primary laparoscopic fundoplication have near normal GERD−HRQL scores? Are the patients satisfied with their decision to undergo surgery at long-term follow-up? Are the results following redo laparoscopic fundoplication as good as with primary laparoscopic fundoplication?
IIP > read on here > http://www.endonurse.com…
…Patients undergoing laparoscopic fundoplication […]
NDO Plicator > Facilitate transgastric natural orifice translumenal endoscopic surgery NOTES > Closure of the transgastric defect > Endolumenal therapy > NOTES > Endoscopy > GERD > Minimally invasive surgery > Society of American Gastrointestinal and Endoscopic Surgeons SAGES > Annual Meeting in April 2007 in Las Vegas Nevada
The NDO Plicator is a device developed for endoscopic treatment of gastroesophageal reflux disease GERD by approximation of tissues together with a double-pledgeted U-stitch…
IIP > Read on here…
…A standardized 12-mm gastrotomy was created endoscopically in four pigs using a combination of needle-knife cautery and balloon dilation. As the endoscope was removed, a Savary soft-tipped […]
EndoGastric Solutions > Results of EsophyX Multi-Center GERD Study > Transoral incisionless fundoplication surgery > No skin incisions > No cutting of vessels > No dissection of the fundus > 85% of patients remain symptom-free > Off daily GERD medication > Chanbe the dependence on pharmaceuticals
Are the effects of daily GERD medication raising concerns that there are additional detrimental effects of pharmaceuticals that should be avoided? Is EsophyX a technology that advances the treatment of GERD forward? Is the discontinue of GERD medications especially important for women in the face of osteoporosis?
IIP > Read on here…
EndoGastric Solutions, the world leader […]
Natural Orifice Transluminal Endoscopic Surgery NOTES for GERD > No Scar Surgery > Incisionless Surgical Techniques > Bard EndoCinch system > NDO Plicator system > EDS system with Sew-Right > Endoscopic Gastroplasty > Technology and the Clinical Circumstances > Implantation of PMMA microbeads > Gatekeeper > Plexiglass implantation > Enteryx System > What is next in 2008?
Does the development of innovative NOTES devices for improving the function of the lower esophageal sphincter LES continue? What role will Polymethylmethacrylate PMMA beads play in the thicken of the tissue and the strengthen of the LES when the microbeads are implanted in local tissue adjacent to the LES? Will the promising work in Endoscopic […]
Endoluminal Radiofrequency Ablation of Barrett’s Esophagus > Barrett’s esophagus may lead to esophageal adenocarcinoma > Endoscopic Ablation of Intestinal Metaplasia with High Grade Dysplasia > Balloon-based Ablation System > BÂRRX Medical’s Ablation System > Study on efficacy for patients with Fundoplication > Elimination of all Barrett’s tissue in all patients as the ultimate goal
Does the BÂRRX Medical’s Ablation System make a favorable impact on the most dangerous grade of Barrett’s esophagus? Have studies validated the performance and efficacy of the HALO ablation systems for treating Barrett’s esophagus? What are the optimal treatment parameters for treating HGD in patients who otherwise would be subjected to surgical esophagectomy?
IIP > justin […]
Olympus Corporation Wants To Acquire Gyrus Group > Endoscopes Married With Energy Device For Tissue Take Down And Fusion > Olympus Expands Medical Systems Business In Minimally Invasive Systems
Are Japanese medical companies looking overseas in search of both markets and technology? Is the world’s biggest maker of endoscopes with 70% of the global market now targeting the disposable device segment? Is the device market for Minimally invasive surgeries in greater demand as societies around the world age?
IIP > justin > […]
EnteroMedics Inc. Announces Initial Public Offering IPO > Development Stage Medical Device Company > Neuroblocking Technology > VBLOC™ Vagal Blocking Therapy With Maestro System For Treatment Of Obesity
Will neuroblocking technology and VBLOC™ vagal blocking therapy be successful in treating obesity? Why was the planned initial public offering at 5 million shares for an estimated price of $14 to $16 reduced to $8 per share? Do investors appreciate EnteroMedics Inc, a development stage medical device company as a viable option to treat obesity?
[…]